Primary central nervous system lymphomas (PCNSL) are rare CNS tumors that harbor a
conspicuously longer diagnostic delay compared to other malignant brain tumors. The gold …

Primary central nervous system lymphoma (PCNSL) is a rare subtype of extranodal non‑
Hodgkin lymphoma that is unique and different from systemic diffuse large B‑cell …

It is often challenging to distinguish cancerous from non-cancerous lesions in the brain
using conventional diagnostic approaches. We introduce an analytic technique called Real …

Primary central nervous system lymphoma (PCNSL) is a highly aggressive brain tumor with
poor prognosis if no treatment. The activation of the NF-κB (nuclear factor kappa-B) is the …

Background: Diagnostic delay and neurologic deterioration are still a problem for the
treatment of rapidly progressing CNS lymphoma (CNSL); there is an unmet need for a …

Primary central nervous system lymphoma (PCNSL) is an aggressive variant of extranodal
non-Hodgkin lymphoma (NHL) arising within the brain, leptomeninges, eyes, or spinal cord …

Introduction Venous thromboembolism (VTE) is a known complication of malignancy. While
brain tumors in general predispose to VTE, the incidence in primary central nervous system …

The management of older individuals (≥ 60 years) with primary central nervous system
lymphoma remains a clinical challenge. Identification of optimal therapy and delivering …

Simple Summary We present a review of the most relevant epidemiological, diagnostic and
therapeutic aspects of primary central nervous system lymphoma (PCNSL) in elderly …

Abstract Background Primary CNS lymphoma (PCNSL) is a highly aggressive non-Hodgkin
lymphoma (NHL) that occurs in the CNS (eg brain, meninges, spinal cord, cerebrospinal …